What is the main purpose of this Merck 8-K filing?

The main purpose of this filing is to disclose that Merck is making available Frequently Asked Questions (FAQs) published by Schering-Plough Corporation. It directs investors to the Schering-Plough website for the actual content of these FAQs.

Where can I find the actual content of the FAQs mentioned in the filing?

The FAQs dated December 18, 2008, are posted on the Schering-Plough website at www.schering-plough.com under Investor Relations/Investor FAQs. Investors need to visit that site to access the information.

Does Merck provide any new information or updates in this filing?

No, this filing does not contain new or original information directly from Merck. It serves as a reference to information published by Schering-Plough, indicating a potential relevance of Schering-Plough's communications to Merck's stakeholders.

What is the significance of Schering-Plough's statement about not updating the FAQs?

Schering-Plough's statement that they undertake no obligation to update the FAQs means that the information presented is as of December 18, 2008, and may not reflect subsequent developments. Investors should pay close attention to the date of the information when reviewing the FAQs.

MRK 8-K: Regulation FD — Dec 18, 2008

Summary

This Merck & Co., Inc. (MRK) 8-K filing from December 18, 2008, is primarily a disclosure of information provided by Schering-Plough Corporation. The key takeaway for investors is that Merck is referencing FAQs published by Schering-Plough, dated December 18, 2008, and available on Schering-Plough's investor relations website. This suggests that any significant announcements or clarifications relevant to Merck's interests (potentially related to a merger, partnership, or product) would be found within these Schering-Plough FAQs.

Key Highlights

1Merck is furnishing Frequently Asked Questions (FAQs) published by Schering-Plough Corporation as of December 18, 2008, as Exhibit 99.1.
2These FAQs are available on the Schering-Plough website under Investor Relations/Investor FAQs.
3The filing itself does not contain original information from Merck but rather directs investors to Schering-Plough's disclosures.
4Investors should consult the Schering-Plough website for the content of these FAQs.
5Schering-Plough explicitly states no obligation to update the FAQs, highlighting the importance of noting the date of information.
6This filing suggests potential strategic or operational connections between Merck and Schering-Plough at the time.